Sensei Biotherapeutics, Inc.
Price Action
Technical Summary
EMERGING TRENDSensei Biotherapeutics, Inc. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is weak (RS Rating: 22), showing significant lag compared to the market leaders. Earnings contraction of 486% provides fundamental context to the price action. Investors should exercise caution due to high volatility (123% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $16.07 | -13.82% | BELOW |
| 50 SMA | $23.20 | -40.31% | BELOW |
| 100 SMA | $23.06 | -39.93% | BELOW |
| 150 SMA | $18.51 | -25.16% | BELOW |
| 200 SMA | $16.33 | -15.21% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SNSE in an uptrend right now?
SNSE has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is SNSE overbought or oversold?
SNSE's RSI (14) is 35. The stock is in neutral territory, neither overbought nor oversold.
Is SNSE outperforming the market?
SNSE has a Relative Strength (RS) Rating of 22 out of 99. SNSE is currently lagging the broader market.
Where is SNSE in its 52-week range?
SNSE is trading at $13.85, which is 38% of its 52-week high ($36.76) and 25% above its 52-week low ($6.33).
How volatile is SNSE?
SNSE has a Beta of 1.56 and 52-week volatility of 123%. It's more volatile than the S&P 500 - expect bigger swings.